IPO Trending
MONOPHARMASME / NSEListed

Mono Pharmacare Limited

Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.

₹26 - ₹2813.47x sub
Listed Price29.00
Listing Gain+3.57%
FinancialsBalance sheet and operational figures in Crores
Metric Breakdown

Revenue

Latest (Mar 2020)1168.9 Cr
Revenue Trend (₹ in Crores)
0.01.4k2.8k4.3kMar 2023Mar 2022Mar 2021Mar 2020
PeriodRev (Cr)PAT (Cr)AssetsDebt
Mar 20201,168.901.99871.70633.46
Mar 20212,837.839.511,122.46608.03
Mar 20223,710.2735.091,438.31643.93
Mar 2023006,257.390
Key Performance Indicators (KPIs)
PeriodEPSROEROCEP/E (Pre)P/E (Post)
Values1.999.01%10.34%040
Mono Pharmacare Limited IPO Financials | GMP, Allotment & Financials | IPO Trending